Persistence with mirabegron, a beta-3 adrenoceptor agonist, versus antimuscarinics in patients with over-active bladder: Early UK experience.
Phase of Trial: Phase IV
Latest Information Update: 11 Sep 2015
At a glance
- Drugs Mirabegron (Primary) ; Oxybutynin; Solifenacin; Tolterodine
- Indications Overactive bladder
- Focus Therapeutic Use
- 11 Sep 2015 New trial record